An Astra Zeneca spokesman said the company had received no formal notification from authorities to stop selling the drug.
The company’s chief executive, Martin Schuster, said Astra was confident it would continue to sell the drug and said it would have a more transparent and transparent governance structure.
“We will continue to meet with the relevant authorities and provide updates as soon as we are able,” he said.
The AFP said it had not been informed by Astra that it was going to stop sales.
The Drug Enforcement Administration (DEA) said the drug, called loratadine, was not on the drug blacklist.
The DEA, the US Drug Enforcement Agency (DEAC), said it was unable to confirm whether Astra had sold the drug to the US.
“This is a drug we can’t comment on,” DEA spokesman John Binder said.
“But we do know that the drug is on the DEA’s drug list.”
The DEA has been notified and is working with our law enforcement partners to get this drug off of the DEA list.
“The AFP is investigating Astra’s dealings in the US with the DEA, a spokesman said.
It said Astrayzene was one of more than 80 pharmaceutical companies that had received approval from the US Food and Drug Administration (FDA) to sell a range of medicines, including antibiotics, over the last two years.
The drug is available in Australia under generic names, including Astra and AstraBiosimilars.”
Some of the companies have received approval to sell it under the name Lantadol or Astra, and others have received FDA approval to make this product available in the United States,” AFP Commissioner Neil Gaughan said.
Drug abuse: Astra has had a string of scandals, including one involving the deaths of a child, including two who died after taking the drug for months.
Mr Gaughon said the AFP would be investigating Asta’s dealings with the United Kingdom and Australia.
The New South Wales Health Department has reported that Astra supplied the drug Lantatadone to an organisation linked to the former Liberal Party leader, Peter Slipper, in an attempt to avoid a ban on its sale to Australia.
It also reported that the company paid $15,000 to a company owned by the son of a former state premier to help him secure a $5 million loan to run his company.